Clinical Trial

Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Randomized clinical trial to assess the effectiveness and tolerability of Mela B3 serum in combination with 35% glycolic acid peel vs. 35% glycolic acid peel for the treatment of various hyperpigmentation conditions (melasma, post-inflammatory hyperpigmentation and solar lentigo) and signs of aging in a population of participants from the Autonomous City of Buenos Aires, Argentina.
Trial Details
NCT Number NCT07429786
Lead Sponsor Cosmetique Active International
Conditions Hyperpigmentation, Melasma, Solar Lentigo, Peeling
Enrollment 80 participants
Start Date 2026-03-04
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-24